Is so-called oncocytic papillary renal cell carcinoma a distinct entity? A multi-institutional morphologic, immunohistochemical and fluorescence in-situ hybridization study
Khaleel I. Al‐Obaidy(Indiana University School of Medicine), David Grignon, John N. Eble(Indiana University – Purdue University Indianapolis), Sean R. Williamson(Cleveland Clinic), Liang Cheng(Brown University), Nilesh Gupta(Henry Ford Health System), W Sakr, Muhammad T. Idrees(Indiana University School of Medicine)
Unknown
January 1, 2018
Cited by 0
Related Papers
Classification of renal cell carcinoma
|Cancer|1997|878
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
|Modern Pathology|2017|404
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
|Clinical Cancer Research|2013|358
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
|Cancers|2021|289